Drug recall · January 1, 2014
Sumatriptan Succinate Injection recall
Why: Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.
- Lots / codes
Lot#: C636242, Exp: 06/15
- Quantity
- 9,743 cartridges
- Company
- GlaxoSmithKline, LLC., Zebulon, NC
- Distribution
- Nationwide
- Initiated
- November 6, 2013 · Voluntary: Firm initiated
- Classified
- December 24, 2013
- Reported
- January 1, 2014
- Ended
- August 20, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sumatriptan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.